Events

Research highlights include advancements in theranostics, a clinical trial in prostate cancer, the Hedgehog signaling pathway, cutting off tumor growth, and how older adults consume low-credibility health information.

Three executive leaders describe how they see Huntsman Cancer Institute innovating cancer care and research in 2026.

A breakthrough clinical trial for a deadly brain tumor, how fatty acids affect breast cancer risk, upending our ideas about melanoma’s origins, and a new drug for sarcoma patients.

A grant to study endometrial cancer and progestins, a review of gaps in skin cancer care, an immunotherapy system for multiple myeloma patients, and how cell identity affects tumor growth.

New drug therapy gives hope to advanced melanoma patients, personalized exercise plans enhance lung cancer patient recovery, and patient receives first allogeneic stem cell transplant from a deceased organ donor.

Three executive leaders describe how they see Huntsman Cancer Institute advancing cancer care and research in 2025 and beyond, including increasing cancer care access for all.